Giuseppe Pugliese

5PUBLICATIONS
29CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2026
Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cells.

Alexandria R Mitchell, Yiran Chen, Giuseppe Pugliese

|Mar 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy.

David M Davies, Giuseppe Pugliese, Ana C Parente Pereira

|Feb 01, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma.

Chiara Chiavelli, Malvina Prapa, Giulia Rovesti

|Mar 11, 2023
Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications.

Cinzia Baldessari, Stefania Pipitone, Eleonora Molinaro

|Apr 08, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.

Marie-Eve Wedge, Victoria A Jennings, Mathieu J F Crupi

Pageof 1

Frequent Collaborators

2 joint publications

John Maher

1 joint publications

Marie-Eve Wedge

1 joint publications

Taylor Jamieson

1 joint publications

Brian J Laight